DrugDashboards
← Home
Manufacturing facility

Baxter Healthcare Corporation

A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step β€” so if this plant has a problem, these are the products that could be affected.

Country
United States
Registered address
250 Road 144, Jayuya, Puerto Rico (PR) 00664, United States (USA)
Operations here
analysislabelmanufacturepacksterilize
FDA identifiers
FEI 2618677 Β· DUNS 189326168

FDA inspection history

Outcomes of closed FDA inspections at this site (drug and biologic program areas).

  • VAIDrug Quality Assurance2024-07-19
  • NAIDrug Quality Assurance2021-07-30
  • VAIDrug Quality Assurance2018-12-21
  • OAIDrug Quality Assurance2016-10-03
  • OAIDrug Quality Assurance2015-05-01
  • OAIDrug Quality Assurance2014-02-11
  • NAIDrug Quality Assurance2013-09-26
  • OAIDrug Quality Assurance2013-04-19
  • VAIDrug Quality Assurance2011-11-03
  • NAIDrug Quality Assurance2011-04-27
  • OAIDrug Quality Assurance2010-08-26
  • NAIBioresearch Monitoring2009-05-14
  • VAIDrug Quality Assurance2009-05-14
  • NAIDrug Quality Assurance2009-04-17
  • NAIPostmarket Surv. and Epidemiology2009-04-17

Drugs this plant is listed as making

18 distinct drugs across 62 products name this site in their FDA label.

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.

Baxter Healthcare Corporation β€” facility profile Β· DrugDashboards